Germany-based Vetter has opened a new business entity in Tokyo, Japan. Vetter is a leading manufacturer of drug-delivery systems, servicing the top-ten pharma/biotech companies worldwide along with mid-size firms and emerging startups.

Hiroaki Suzuki in his role as Business Development Manager for Vetter Pharma International Japan K.K. will lead Vetter's business activities in Japan. He will report to Chervee Ho, Director Key Account Management Asia Pacific, based in Singapore.

Vetter indicates that the new office underlines the importance of Japan for its business activities. As the second largest pharmaceutical single market, Japan is home to a number of leading global companies which offer a promising injectable pipeline. It is also a point of departure for several established Japanese companies for increasing their global reach.

The new office will support Vetter's customer relations and aid in the development of new business within Japan, and strengthen its global position, particularly in selected Asia Pacific markets. As a strategic partner, Vetter supports its worldwide clients through every phase of their drug product's lifecycle, from early product development to launch to commercial supply.

"For more than 35 years, the name Vetter has been synonymous with high-quality aseptically prefilled drug-delivery systems. With our new office in Japan, we continue to build upon that history with a further demonstration of our strategy to better service the needs of our growing customer base worldwide, including Asia," said Udo J. Vetter, Chairman of the Advisory Board and member of the owner family.

"Our presence in Japan will help to increase awareness of Vetter's services in this growing healthcare market by presenting our expertise and market position onsite," added Managing Director Peter Soelkner. "Following the creation of our Asia Pacific hub in Singapore last year, the new office is a further development, establishing a dedicated presence in the most important single market of the region. This activity affords us the opportunity to strengthen personal contacts with national audiences."